We observed a significant decrease in viral mRNA with PERK inhibitor treatment at the early stages of infection, but observed no significant difference at later timepoints (36 hpi) despite a significant decrease in viral protein expression (Figure 6C,F). This evidence concerns the gene EIF2AK3 and infection.